Tris Pharma Inc, a specialty pharmaceutical company, announced yesterday that it has named Jonathan N Provoost as its new vice president and general counsel.
In the new role, Provoost is to manage all of the company's legal functions.
Provoost has more than 20 years of corporate legal experience, with most of his tenure in large and medium-sized pharmaceutical organisations. His wide range of experience within the legal profession includes management of Intellectual Property, and serving as a chief compliance officer and general counsel, general transactions, litigation and various business activities. Throughout his career he has held positions of increasing management responsibility at Ikaria, PTC Therapeutics, Kos Pharmaceuticals, Bristol-Myers Squibb and Exxon Mobil Corporation. He most recently served as general counsel for Business Development & Licensing at Mallinckrodt Pharmaceuticals.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer